Notícias Sutro Biopharma Inc - STRO | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sutro Biopharma Inc (STRO)
Sutro Biopharma Inc (STRO) Notícias

Sutro Biopharma Inc (STRO)

1,88

0,06

(3,30%)

Fechado 23 Dezembro 6:00PM

Atrasado por 15 minutos

1,97

0,09

(4,79%)

Após o horário de negociação: 9:36PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 8-K - Current report

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

Form 4 - Statement of changes in beneficial ownership of securities

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024

Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Sutro Biopharma

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições